Sartorius Stedim Biotech header image

Sartorius Stedim Biotech

DIM

Equity

ISIN FR0013154002 / Valor 32518471

Euronext - Euronext Paris (2026-03-27)
EUR 165.00-1.23%

Sartorius Stedim Biotech
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sartorius Stedim Biotech is a prominent global player in the biopharmaceutical industry, specializing in the development and manufacturing of biotech medications and vaccines. With a workforce of approximately 9,900 employees and operations in over 30 countries, the company provides a comprehensive range of products and technologies that support all critical stages of biopharmaceutical production and process development. Its offerings include cell line technologies, cell culture media, bioreactors, and various solutions for the separation, purification, and concentration of biological intermediates and finished products, as well as their storage and transportation. Headquartered in Aubagne, France, Sartorius Stedim Biotech is a subsidiary of Sartorius AG, which holds a significant majority of its share capital and voting rights. The company is publicly traded on the Euronext stock exchange in Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-10.8%1Y
-46.1%3Y
-53.8%5Y

Performance

37.9%1Y
44.3%3Y
43.4%5Y

Volatility

Market cap

18533 M

Market cap (USD)

Daily traded volume (Shares)

132,409

Daily traded volume (Shares)

1 day high/low

187.35 / 183.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.82%USD 72.15
Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.96%USD 84.61
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38